Key statistics
On Tuesday, Pharming Group NV (PHAR:NMQ) closed at 16.30, -23.62% below its 52-week high of 21.34, set on Jan 27, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 15.69 |
|---|---|
| High | 16.50 |
| Low | 15.65 |
| Bid | 8.10 |
| Offer | 20.00 |
| Previous close | 15.42 |
| Average volume | 30.77k |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
Announcements
- Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
- Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
- Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
- Pharming Group reports preliminary 2025 revenues and announces Investor Day
- Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
- Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow
- Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
- Pharming Group to report third quarter 2025 financial results and provide business update on November 6
- Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
More ▼
